Medicine
| ISSN | 11775475, 11775491 |
|---|---|
| Country | New Zealand |
| Publisher | Dove Medical Press Ltd. |
| Subject Areas | Medicine |
| Publication Type | Journals |
| Active Years | 1988, 2007-2021 |
| Website | Visit journal |
| JIF 2022–2023 | 5.300 |
An international peerreviewed journal focusing on the pathophysiological rationale for and clinical application of Biologic agents in the management of autoimmune diseases cancers or other pathologies where a molecular target can be identified.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 4.212 | 4.855 | 4.534 |
| 2021 | 5.172 | 4.521 | 4.098 |
| 2020 | 4.278 | 3.694 | 3.612 |
| 2019 | 2.781 | 2.880 | 2.621 |
| 2018 | 2.129 | 2.213 | 2.667 |
| 2017 | 2.794 | 3.411 | 3.892 |
| 2016 | 3.737 | 4.215 | 3.757 |
| 2015 | 4.878 | 3.916 | 3.843 |
| 2014 | 4.219 | — | — |
| 2013 | 3.245 | — | — |
| 2012 | 3.111 | — | — |
| 2011 | 2.650 | — | — |
| 2010 | 1.862 | — | — |
| 2009 | 0.255 | — | — |
| 2008 | 0.167 | — | — |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 1.276 |
| 2022 | 1.176 |
| 2021 | 0.832 |
| 2020 | 0.948 |
| 2019 | 0.697 |
| 2018 | 0.683 |
| 2017 | 1.084 |
| 2016 | 1.133 |
| 2015 | 1.172 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 47.000 |
| 2022 | 44.000 |
| 2021 | 41.000 |
https://www.dovepress.com/author_guidelines.php